New clinical trial seeks alternatives for head and neck cancer patients unable to use cisplatin

News Medical

Center

Factuality

Ownership

New clinical trial seeks alternatives for head and neck cancer patients unable to use cisplatin

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug cisplatin.